November 2026
Largest Public Companies in Ireland
Benchmark revenue and EBITDA valuation multiples for public comps like
CRH, Experian, Ryanair, Smurfit WestRock and Bank of Ireland.
 | CRH is a global building materials group headquartered in Dublin, Ireland and New York, which moved its primary stock listing to the New York Stock Exchange in June 2023. It was formed on 20 October 1970 through the merger of Cement Limited and Roadstone Limited and listed on the Irish Stock Exchange in 1973. It operates through CRH Americas, covering materials and building solutions across 48 US states and 7 Canadian provinces, and CRH International, with operations in Europe, Australia and the Philippines, from about 3,961 locations in 28 countries. For 2025 it reported revenue of US$37.4 billion and net income of US$3.75 billion with about 83,000 employees, and it earns revenue from aggregates, cement, asphalt, ready-mixed concrete and building products. Its acquisitions include the EUR 6.5 billion Lafarge and Holcim assets in 2015, which included Tarmac in the UK, and Ash Grove Cement for US$3.5 billion in 2018. Jim Mintern is chief executive. | $95 | -21% | $63B | $81B | 2.2x | 10.6x | ||
| Experian is one of the leading credit bureaus in North America and the United Kingdom, providing the consumer information that is the basis for making lending decisions. The company also provides decision analytics, marketing data, and direct-to-consumer credit products and services. Roughly one quarter of the company's revenue is generated outside of North America and the United Kingdom, primarily in Latin America and Asia. | $41 | -6% | $36B | $41B | 4.9x | 13.7x | ||
| Ryanair is Europe’s largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 daily flights across more than 220 airports in 36 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 “Gamechanger” variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe. | $29 | -12% | $30B | $28B | 1.6x | 6.6x | ||
| Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe. | $44 | +24% | $23B | $36B | 1.2x | 8.6x | ||
| Bank of Ireland Group PLC is an Irish financial services group operating mostly in Ireland and the United Kingdom. Services include mortgages, business, and corporate lending, term loans, leasing, foreign exchange, life assurance, and pension products, among others. The bank's trading divisions include Retail Ireland, Wealth and Insurance, Retail UK, Corporate and Commercial , and Group Centre. The bank generates the majority of its revenue from Retail Ireland and serves consumer and business customers across a broad range of segments and sectors. Revenue is also derived from fees for a range of banking and transaction services. The bank has access to distribution in the United Kingdom via its relationship as a financial services partner with the nation's post office. | $21 | +15% | $20B | $20B | 4.2x | - | ||
| Kingspan is a global leader in high-performance insulation and building envelope solutions. It's been a serial acquirer of insulation companies since the 1980s and boasts a well-known brand that resonates with risk-averse project specifiers. In recent years, it has focused on expanding its product scope beyond insulation and now offers a comprehensive suite of products and solutions for the broader building envelope. Today, its insulated building envelopes segment generates 82% of group sales, while the rest comes from Advansys, which manufactures power, cooling, and containment solutions for data centers. | $107 | +25% | $19B | $22B | 2.1x | 16.0x | ||
| Kerry Group is a leading taste and ingredient technology company and an innovation partner for the food, beverage, and pharmaceutical sectors. The company has more than 200 locations that supply clients in more than 50 countries. Its taste and nutrition unit earns around 67% of its revenue from developed countries and 33% from the developing world, servicing a wide range of sectors, such as meat, meals, snacks, dairy, drinks, and pharmaceuticals. Kerry has expanded through a combination of organic development and dozens of tuck-in acquisitions. | $110 | +19% | $17B | $20B | 2.6x | 15.8x | ||
| Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon’s services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market. | $205 | +9% | $15B | $18B | 2.2x | 22.1x | ||
| Jazz Pharmaceuticals is a biopharmaceutical company with corporate headquarters in Dublin, Ireland. It develops and commercializes medicines principally in neuroscience and oncology, with research programs ranging from early development through later clinical stages. Its neuroscience business includes treatments for sleep disorders and epilepsy. Its oncology activities address blood cancers and solid tumors, including patient populations with limited treatment options. The company combines internal research and development with acquisitions and partnerships that add medicines and development candidates to its portfolio. Commercial revenue is generated primarily from sales of approved pharmaceutical products. Jazz also maintains manufacturing and business operations in multiple countries to support development and supply. Its portfolio includes medicines obtained through the acquisition of GW Pharmaceuticals, including the epilepsy treatment Epidiolex. | $235 | +33% | $15B | $18B | 4.2x | 67.8x | ||
| In 2016, Irish company Paddy Power merged with UK firm Betfair to form online gaming operator Flutter Entertainment. Today, Flutter has the top digital revenue share in the US, UK and Ireland, Australia, Italy, and many other countries. Some of its leading brands are FanDuel in the US, Sky Betting & Gaming and Paddy Power in the UK and Ireland, Sportsbet (acquired by Paddy Power beginning in 2009) in Australia, and Sisal in Italy. As of Dec. 31, 2024, the company offered products in over 100 countries and had 13.9 million average monthly users. In 2024, sports betting was 56% of revenue, online gaming 40%, and fantasy sports, horse racing, and other 4%. The company is scheduled to launch a predictive sports betting platform in late 2025. | $82 | -61% | $14B | $24B | 1.4x | 12.3x | ||
| Glanbia PLC is a ingredient and branded performance nutrition manufacturer company. Company offer an incredible breadth of expertise in nutrition. It works with food and beverage companies and sell the products across the globe . The company segments include Performance Nutrition (PN), Health & Nutrition (H&N) and Dairy Nutrition (DN). The company generates majority of the revenue from Performance Nutrition segment. Geographically, it has majority revenue from North America followed by Europe and Asia. | $22 | +27% | $5.3B | $6.1B | 1.5x | 15.7x | ||
| Cairn Homes PLC is an Irish homebuilder. Its core activity is to design and develop properties for residential purposes, majorly in the suburbs of Dublin City. The company's portfolio predominantly comprises single-family homes and apartments that form a minor share. Its sales of residential properties generates the majority of the company's revenue. The company has various Projects like New Homes, Buildings, Commercial and Retail, and Sven Mills. Company's business has the resources and capabilities to deliver a choice of new homes where people want to live now and into the future. Creating new communities of connection and belonging, building towards an Ireland where everyone can thrive. | $3 | +32% | $1.9B | $2.1B | 2.0x | 11.1x | ||
| Permanent TSB Group Holdings PLC is a full-service Retail and SME bank in Ireland. The company serves individual customers and small- to medium-sized enterprises through a multi-channel distribution model. Such channels include Branch Network, Brokers, Direct, Digital, and SME. It provides mainstream transactional banking, lending, saving, and deposit-taking services. | $3 | -6% | $1.8B | $1.8B | 2.5x | - | ||
| Glenveagh Properties PLC is engaged in homebuilding in Ireland. The company is organized into two key reportable segments. The Homebuilding segment is principally focused on delivering high-quality own-door single-family focused developments, with a particular emphasis on Dublin, the Greater Dublin Area, and Cork. The Partnerships segment focuses on the delivery of sustainable communities across Ireland through a mix of suburban single-family focused and urban multi-family focused developments. The firm generates the majority of its revenue from the Homebuilding segment. | $3 | +21% | $1.4B | $1.9B | 1.8x | 11.0x | ||
| Irish Continental Group PLC is a transportation and logistics company domiciled in Ireland. The company organizes itself into two segments: ferries and containers & terminals. The ferries segment transports passengers and vehicles on roll-on/roll-off ferries and chartering vessels. The containers and terminal segment transports cargo and provides stevedoring and other related terminal services. The company derives maximum revenue from the Ferries Segment. Its geographical segments are Ireland, the United Kingdom, the Netherlands, Belgium, France, Poland, Germany, Austria, and Other. | $9 | +34% | $1.3B | $1.6B | 2.1x | 9.3x | ||
| GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development. | $19 | +23% | $1.3B | $915M | ||||
| Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies. | $5 | +12% | $1.3B | $1.8B | ||||
| Greencoat Renewables PLC is a sector-focused listed renewable infrastructure company, investing in renewable electricity generation assets. The Group is engaged in a single segment of business, being investment in renewable infrastructure to generate investment returns while preserving capital. The Group presents the business as a single segment comprising a homogeneous portfolio. It geographically operates in the Republic of Ireland, Germany, France, Sweden, and Spain. | $1 | +9% | $978M | $2.3B | ||||
| FBD Holdings PLC is a property and casualty insurer, that looks after the insurance needs of farmers, consumers, and business owners. The company operates through two segments: general insurance and other group activities. All of its operations are located in Ireland. | $22 | +24% | $798M | $798M | ||||
| Fineos Corp Holdings PLC is an Irish company engaged in providing software solutions that include management and administration of policies and claims to the life, accident, and health insurance industry. The company's platform, Fineos AdminSuite, comprises Fineos Absence, Fineos Billing, Fineos Claims, Fineos Payments, and Fineos Provider, among other solutions. | $1 | -34% | $490M | $448M | ||||
| Origin Enterprises PLC is provides a different products, services and specialist expertise to customers operating across the agriculture, environmental and land management markets. Through its manufacturing, research and development, trading, distribution and digital services activities. The group has two reporting segments, Agriculture and Living Landscapes. Majority of revenue comes from Agriculture segment consists of both direct-to farm businesses supplying agronomic advice, services and inputs to arable, livestock, and horticultural growers, and wholesale B2B businesses providing inputs to firms upstream of the grower. It has presence in Ireland and the UK, Continental Europe, and Latin America. Majority of revenue comes from Ireland and the UK. | $4 | +0% | $474M | $640M | ||||
| Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer’s disease (PRX123), Neurodegeneration (PRXPRX019), and Others. | $8 | -26% | $409M | $144M | ||||
| Mincon Group PLC designs, produces, and sells rock drilling tools. Its products are used in the mining exploration, oil and gas production, water well drilling, geothermal drilling, and seismic drilling sectors. Mincon's product offerings include conventional down-the-hole hammers, inverted circulation down-the-hole hammers, horizontal directional drilling systems, mast integration systems, drill pipes, and shock absorbers, among others. It also provides training, after-sales support, and related services to customers through its network of sales and distribution companies. Maximum revenue is derived from the sale of drilling equipment. Geographically, the company generates maximum revenue from Europe, Middle East, Africa (EMEA), followed by the Americas, Australasia, and Ireland. | $1 | +73% | $224M | $242M | ||||
| Hostelworld Group PLC is a social network-powered Online Travel Agent (OTA) focused on the hostel market. It has developed and promoted the Hostelworld brand, operating a two-sided marketplace focused on the hostelling category. The Hostel partners load their bed inventory to the company's platform, which it markets to customers via its website and mobile Android and iOS apps. In addition, the Hostelworld platform has a series of social features on its platform that connect travellers in hostels and cities based on their booking data. Geographically, it derives maximum revenue from Europe, followed by Asia, Africa and Oceania, and the Americas. | $1 | -33% | $136M | $131M | ||||
| Group Eleven Resources Corp is a Canada-based mining company. The company is a mineral exploration company focused on stage zinc exploration in the Republic of Ireland. The company is engaged in the business of exploration and evaluation of mineral properties. The company's project consists of Ballinalack, PG West, Stonepark, Silvermines, and others. | $0 | +64% | $136M | $126M | ||||
| Cirmaker Technology Corp is a U.S-based financial services firm dedicated to supporting clients facing financial hurdles. With a focus on the European market, including pivotal regions in Ireland and beyond, Company is committed to providing solutions that bridge the gap left by traditional banking systems. | $0 | +0% | $42M | $83M | ||||
| Davion Healthcare PLC is focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable. It designs, develops, and patents medical products and non-diagnostic devices and then licenses the manufacturing, marketing, sales, and distribution rights for its products to regional or world-wide commercial partners. The company has been operating as a single segment. Its products are BreastCheck, FootFlow, and Testic. | $2 | -- | $40M | $41M | ||||
| Malin Corporation is a publicly listed life-sciences investment company headquartered in Dublin. Founded and admitted to the Irish Stock Exchange's Enterprise Securities Market in 2015, it deploys its own balance-sheet capital into biotechnology, medical-device and healthcare-technology businesses and supports them through development and commercial milestones. Malin historically assembled a portfolio spanning therapeutics, devices and health technology, taking significant minority and, in some cases, controlling positions. Following a series of disposals, including Kymab, Immunocore, CG Oncology and Poseida, the company is managing a smaller group of remaining interests and contingent value rights while returning capital to shareholders. Its shares trade on Euronext Growth Dublin, and its investment returns depend on exits, listed-share sales, milestone payments and royalties from portfolio assets. | $7 | -27% | $29M | $29M | ||||
| Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment. | $7 | +557% | $5M | $137M | ||||
| SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. | $5 | -100% | $4M | $12M | ||||
| Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections. | $0 | -100% | $0K | $23M | ||||
| Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally. | $0 | -100% | $0K | $0K | ||||
| Median | $7 | +9% | $1.3B | $1.7B | 2.0x | 8.6x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.